Mozaffarian D, Benjamin EJ, Go AS, et al. Executive summary: Heart disease and stroke statistics-2016 update A report from the American Heart Association. Circulation. 2016;133(4):447–54.

Article  PubMed  Google Scholar 

King GL, Park K, Li Q. Selective insulin resistance and the development of cardiovascular diseases in diabetes: The 2015 Edwin Bierman Award lecture. Diabetes. 2016;65(6):1462–71.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beckman JA, Creager MA. Vascular complications of diabetes. Circ Res. 2016;118(11):1771–85.

Article  PubMed  CAS  Google Scholar 

Ference BA, Robinson JG, Brook RD, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375(22):2144–53.

Article  PubMed  CAS  Google Scholar 

Brandts J, Ray KK. Novel and future lipid-modulating therapies for the prevention of cardiovascular disease. Nat Rev Cardiol. 2023;20(9):600–16.

Article  PubMed  CAS  Google Scholar 

Taylor SI, Yazdi ZS, Beitelshees AL. Pharmacological treatment of hyperglycemia in type 2 diabetes. J Clin Invest. 2021:131(2):e142243. https://doi.org/10.1172/JCI142243.

Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.

Article  PubMed  Google Scholar 

Gloerich M, Bos JL. Regulating Rap small G-proteins in time and space. Trends Cell Biol. 2011;21(10):615–23.

Article  PubMed  CAS  Google Scholar 

Jaskiewicz A, Pajak B, Orzechowski A. The many faces of Rap1 GTPase. Int J Mol Sci. 2018;19(10):2848. https://doi.org/10.3390/ijms19102848.

Shah S, Brock EJ, Ji K, Mattingly RR. Ras and Rap1: A tale of two GTPases. Semin Cancer Biol. 2019;54:29–39.

Article  PubMed  CAS  Google Scholar 

Wittchen ES, Aghajanian A, Burridge K. Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions. Small GTPases. 2011;2(2):65–76.

Article  PubMed  PubMed Central  Google Scholar 

Caron E. Cellular functions of the Rap1 GTP-binding protein: A pattern emerges. J Cell Sci. 2003;116(Pt 3):435–40.

Article  PubMed  CAS  Google Scholar 

Li Y, Yan J, De P, et al. Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J Immunol. 2007;179(12):8322–31.

Article  PubMed  CAS  Google Scholar 

Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC 2nd. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest. 2005;115(3):680–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Frische EW, Zwartkruis FJ. Rap1, a mercenary among the Ras-like GTPases. Dev Biol. 2010;340(1):1–9.

Article  PubMed  CAS  Google Scholar 

Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: Critical elements in the control of small G proteins. Cell. 2007;129(5):865–77.

Article  PubMed  CAS  Google Scholar 

de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 1998;396(6710):474–7.

Article  PubMed  Google Scholar 

Sartre C, Peurois F, Ley M, et al. Membranes prime the RapGEF EPAC1 to transduce cAMP signaling. Nat Commun. 2023;14(1):4157.

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Rooij J, Boenink NM, van Triest M, Cool RH, Wittinghofer A, Bos JL. PDZ-GEF1, a guanine nucleotide exchange factor specific for Rap1 and Rap2. J Biol Chem. 1999;274(53):38125–30.

Article  PubMed  Google Scholar 

Gotoh T, Hattori S, Nakamura S, et al. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol Cell Biol. 1995;15(12):6746–53.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Crittenden JR, Bergmeier W, Zhang Y, et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med. 2004;10(9):982–6.

Article  PubMed  CAS  Google Scholar 

Lezoualc’h F, Fazal L, Laudette M, Conte C. Cyclic AMP sensor EPAC proteins and their role in cardiovascular function and disease. Circ Res. 2016;118(5):881–97.

Article  PubMed  CAS  Google Scholar 

Rubinfeld B, Munemitsu S, Clark R, et al. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell. 1991;65(6):1033–42.

Article  PubMed  CAS  Google Scholar 

Kurachi H, Wada Y, Tsukamoto N, et al. Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product. J Biol Chem. 1997;272(44):28081–8.

Article  PubMed  CAS  Google Scholar 

Pannekoek WJ, Vliem MJ, Bos JL. Multiple Rap1 effectors control Epac1-mediated tightening of endothelial junctions. Small GTPases. 2020;11(5):346–53.

Article  PubMed  Google Scholar 

Onodera Y, Nam JM, Bissell MJ. Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways. J Clin Invest. 2014;124(1):367–84.

Article  PubMed  CAS  Google Scholar 

Sayyah J, Bartakova A, Nogal N, Quilliam LA, Stupack DG, Brown JH. The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growth. J Biol Chem. 2014;289(25):17689–98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Itoh M, Nelson CM, Myers CA, Bissell MJ. Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells. Cancer Res. 2007;67(10):4759–66.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lyle KS, Raaijmakers JH, Bruinsma W, Bos JL, de Rooij J. cAMP-induced Epac-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics. Cell Signal. 2008;20(6):1104–16.

Article  PubMed  CAS  Google Scholar 

Valles AM, Beuvin M, Boyer B. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J Biol Chem. 2004;279(43):44490–6.

Article  PubMed  CAS  Google Scholar 

Looi CK, Hii LW, Ngai SC, Leong CO, Mai CW. The role of Ras-associated protein 1 (Rap1) in cancer: Bad actor or good player? Biomedicines. 2020;8(9).

Shapiro MD, Tavori H, Fazio S. PCSK9: From basic science discoveries to clinical trials. Circ Res. 2018;122(10):1420–38.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Leander K, Malarstig A, Van’t Hooft FM, et al. Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors. Circulation. 2016;133(13):1230–9.

Article  PubMed  CAS  Google Scholar 

Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34(2):154–6.

Article  PubMed  CAS  Google Scholar 

Horton JD, Cohen JC, Hobbs HH. Molecular biology of PCSK9: Its role in LDL metabolism. Trends Biochem Sci. 2007;32(2):71–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sun H, Krauss RM, Chang JT, Teng BB. PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction. J Lipid Res. 2018;59(2):207–23.

Article  PubMed  CAS  Google Scholar 

Karagiannis AD, Liu M, Toth PP, et al. Pleiotropic anti-atherosclerotic effects of PCSK9 inhibitors from molecular biology to clinical translation. Curr Atheroscler Rep. 2018;20(4):20.

Article  PubMed  Google Scholar 

Momtazi-Borojeni AA, Sabouri-Rad S, Gotto AM, et al. PCSK9 and inflammation: A review of experimental and clinical evidence. Eur Heart J Cardiovasc Pharmacother. 2019;5(4):237–45.

Article  PubMed  Google Scholar 

Katsuki S, Kumar Jha P, Lupieri A, et al. Proprotein convertase subtilisin/kexin 9 promotes macrophage activation via LDL receptor-independent mechanisms. Circ Res. 2022;131(11):873–89. https://doi.org/10.1161/CIRCRESAHA.121.320056.

Article  PubMed  PubMed Central